UBS AG - ENZON PHARMACEUTICALS INC ownership

ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 80 filers reported holding ENZON PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AG ownership history of ENZON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$764,000
+2.7%
707,964
-1.0%
0.00%0.0%
Q2 2014$744,000
+2.6%
715,405
+1.6%
0.00%0.0%
Q1 2014$725,000
-11.9%
704,078
-0.8%
0.00%0.0%
Q4 2013$823,000
-32.0%
709,857
-1.4%
0.00%0.0%
Q3 2013$1,210,000
-14.4%
720,275
+1.9%
0.00%
-50.0%
Q2 2013$1,414,000706,8310.00%
Other shareholders
ENZON PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Ancora Advisors LLC 50,000$20,0000.00%
MONARCH CAPITAL MANAGEMENT INC/ 10,000$4,0000.00%
ACADIAN ASSET MANAGEMENT LLC 122,287$50,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 254,200$103,0000.00%
TUDOR INVESTMENT CORP ET AL 47,998$19,0000.00%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 11,181$5,0000.00%
Kistler-Tiffany Companies, LLC 825$00.00%
Tradewinds Capital Management, LLC 200$00.00%
NEXT Financial Group, Inc 60$00.00%
CT Financial Advisors LLC 2,000$810,0000.00%
View complete list of ENZON PHARMACEUTICALS INC shareholders